About AMIVAS US LLC
AMIVAS is a global pharmaceutical company focused on the development, commercialization, and distribution of Artesunate for the treatment of severe malaria. It operates as a US, Australian, and European joint venture with manufacturing in North America and partnerships in Canada, USA, and Europe.
Development of therapeutics for life-threatening diseasesCommercialization and distribution of ArtesunateManufacturing in North AmericaPackaging and supply of Artesunate through global partners
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| Federal contract award | Department of Defense | $4.5M | |
| Federal contract award | Department of Defense | $394K |
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to AMIVAS US LLC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.